Open AccessActive tuberculosis in inflammatory bowel disease patients under treatment from an endemic area in Latin America
Author(s) -
Flora Maria Lorenzo Fortes,
Ney Boa Sorte,
Victor Mariano,
Laíla Andrade,
Fernanda Oliveira,
Monique C A Santos,
Cláudia Ivanilda N Dos Santos,
Catharina A Passos,
Mila Palma Pacheco,
Valdiana Surlo,
Neogélia Almeida,
Jaciane Am Fontes,
Andréa Pimentel,
Raquel Rocha,
Genoile Oliveira Santana
Publication year - 2020
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v26.i44.6993
Subject(s) - inflammatory bowel disease , medicine , tuberculosis , endemic diseases , disease , ulcerative colitis , crohn's disease , inflammatory bowel diseases , gastroenterology , immunology , pathology , virology
There has been an increase in cases of inflammatory bowel disease (IBD) in recent years. There is also greater access and availability of immunosuppressive and biological agents, which increase the risk of opportunistic infection despite improving the quality of life and promoting mucosal healing. Tuberculosis (TB) remains a public health problem, and it has a high incidence in several countries. Therefore, knowledge of the risk of developing TB in patients with IBD is important.